David Ross McGavin

Title: The Innovations of David Ross McGavin

Introduction

David Ross McGavin is an accomplished inventor based in Portage, MI (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for periodontal disease in companion animals. With a total of 2 patents, McGavin's work has the potential to improve the health and well-being of pets.

Latest Patents

One of McGavin's notable patents is a vaccine for periodontal disease. This invention relates to novel bacterial isolates identified by their 16S rRNA DNA, which are responsible for causing periodontal disease in companion animals. The patent includes polynucleotide sequences and polypeptides encoded by these sequences, as well as vaccines that comprise such bacteria, polynucleotides, or polypeptides. Additionally, the patent outlines methods for treating and preventing periodontal disease, along with kits designed for detecting and treating this condition in animals. Another patent focuses on assessing the efficacy of a vaccine against periodontal diseases in animals, further showcasing McGavin's innovative approach to veterinary health.

Career Highlights

Throughout his career, McGavin has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Pfizer Products Inc. His experience in these organizations has contributed to his expertise in developing medical solutions for animals.

Collaborations

Some of McGavin's notable coworkers include John Morgan Hardham and Kendall Wayne King. Their collaboration has likely played a role in advancing the research and development of veterinary vaccines.

Conclusion

David Ross McGavin's contributions to veterinary medicine through his innovative patents demonstrate his commitment to improving animal health. His work in developing vaccines for periodontal disease is a testament to his expertise and dedication to the field.